Filter
1378
Filtered Results: 1378
Text search:
vaccine
trial
Featured
Recommendations
172
New Publications
314
Language
Document type
No document type
627
Studies & Reports
243
Guidelines
242
Manuals
81
Fact sheets
70
Strategic & Response Plan
53
Situation Updates
19
Training Material
16
Resource Platforms
12
Infographics
7
Videos
5
Brochures
2
App
1
Countries / Regions
Global
61
India
42
Kenya
32
Sierra Leone
31
Liberia
31
Nigeria
28
South Africa
27
Ethiopia
24
Western and Central Europe
21
Uganda
20
West and Central Africa
20
East and Southern Africa
18
Brazil
17
Africa
17
Congo, Democratic Republic of
15
Latin America and the Carribbean
14
Russia
14
Guinea
13
Rwanda
12
Eastern Europe
12
Zambia
11
Ukraine
11
Ghana
10
Nepal
10
South Sudan
10
Germany
10
Malawi
10
Syria
9
Bangladesh
9
South–East Asia Region
9
Zimbabwe
8
Tanzania
8
Middle East and North Africa
8
Philippines
7
Cambodia
7
Mozambique
7
Namibia
6
Senegal
5
Myanmar / Burma
5
Vietnam
5
Burkina Faso
4
USA
4
Indonesia
4
Botswana
4
Eastern Europe and Central Asia
4
Asia
4
Cameroon
3
Lebanon
3
Thailand
3
Angola
3
Lesotho
3
Chile
3
Paraguay
3
United Kingdom
3
Guinea-Bissau
2
Côte d’Ivoire / Ivory Coast
2
Jordan
2
Turkey
2
China
2
Sudan
2
Central African Republic
2
Argentina
2
Peru
2
Yemen
2
Venezuela
2
Laos
2
Spain
2
Mali
1
Morocco
1
Niger
1
Haiti
1
Somalia
1
Pakistan
1
Iraq
1
Chad
1
Gambia
1
Malaysia
1
Papua New Guinea
1
Benin
1
Eswatini/ Swaziland
1
Honduras
1
Ecuador
1
Madagascar
1
Mexico
1
Western Pacific Region
1
Albania
1
Southern Africa
1
Bulgaria
1
Iran
1
Gabon
1
Japan
1
Denmark
1
France
1
Tunisia
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
377
Clinical Guidelines
177
Women & Child Health
78
Public Health
77
Key Resources
29
Pharmacy & Technologies
20
Capacity Building
8
Toolboxes
COVID-19
309
TB
111
HIV
109
Ebola
80
AMR
58
Rapid Response
56
NTDs
52
Pharmacy
34
Mental Health
24
Global Health Education
21
Conflict
18
Refugee
17
Planetary Health
17
Health Financing Toolbox
15
NCDs
14
Cholera
12
Zika
12
Caregiver
12
Polio
11
Disability
5
Natural Hazards
4
Specific Hazards
2
The goal of the global outbreak response for monkeypox is to stop human-to-human transmission of monkeypox, with a priority focus on communities at high risk of exposure which may differ according to context, and to effectively use strong public health measures to prevent onward spread of the diseas...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedn...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying ... in a pandemic situation is a complex endeavour, beset with multiple challenges at all levels – local, regional and global. The World Health Organization (WHO) and its partners have prepared this revised guidance document to assist countries update their national deployment and vaccination plans (NDVPs) by leveraging global learnings from past pandemic responses, including the recent COVID-19 vaccination effort. The development and testing of a NDVP would not only advance pandemic preparedness efforts but would also have benefits in terms of increasing national capabilities to manage other health emergencies which require emergency vaccination campaigns.
It will be updated continuously.
Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.
Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in...
The aim of this article is to identify the elements behind the country’s successful COVID-19 rollout as well as lessons and chal lenges derived from this process. The analysis is relevant to many countries today—as they keep searching for strategies to cope with the second year of the COVID-19 p...
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
Malaria vaccine: WHO position paper - March 2022
recommended
Weekly Epidemiological Record No 9, 2022, 97, 61–80
This position paper supersedes the 2016 publication, “Malaria vaccine: WHO position paper-2016.”1 It includes the updated WHO recommendations on the wider use of the RTS,S/AS01 ... for the reduction of malaria morbidity and mortality in children living in areas of moderate to high malaria transmission. It also incorporates findings from the evaluation of the WHO-coordinated Malaria Vaccine Implementation Programme (MVIP), recommended by SAGE and MPAG in 2015, and from additional studies since 2015.
This paper does not include findings on vaccine efficacy in infants first vaccinated at 6–12 weeks of age. Because of the lower vaccine efficacy observed in this age category, WHO did not recommend pilot implementation or RTS,S/AS01 vaccine introduction for these young infants. Recommendations2 on the use of RTS,S/AS01 vaccine were discussed by SAGE and MPAG during a joint session in October 2021; evidence presented at the meeting can be accessed at https://terrance.who.int/mediacentre/data/ sage/SAGE_eYB_Oct2021.pdf
Weekly epidemiological recordRelevé épidémiologique hebdomadaire 29 JULY 2016, 91th YEAR / 29 JUILLET 2016, 91e ANNÉENo 30, 2016, 91, 349–364
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 ... methodology issues there are still insufficient data to make a recommendation, in which case different options for approaching VE evaluations are presented.
An overview of COVID-19 Vaccine AstraZeneca and why it is authorised in the EU. Available in 22 languages
18 Febr. 2021
31 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and ...
Review Article: Journal of Nutritional Health & Food Science
Vitamin Deficiency and Tuberculosis: Need for Urgent Clinical Page 1- 6
